You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells
|
---|---|
Published in |
Experimental Hematology & Oncology, September 2014
|
DOI | 10.1186/2162-3619-3-24 |
Pubmed ID | |
Authors |
Indira Benakanakere, Tyler Johnson, Richard Sleightholm, Virgilio Villeda, Monika Arya, Ravi Bobba, Carl Freter, Chunfa Huang |
Abstract |
Cholesterol plays an important role in cancer development, drug resistance and chemoimmuno-sensitivity. Statins, cholesterol lowering drugs, can induce apoptosis, but also negatively interfere with CD-20 and rituximab-mediated activity. Our goal is to identify the alternative targets that could reduce cholesterol levels but do not interfere with CD-20 in chemo immunotherapy of chronic lymphocytic leukemia (CLL). |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 23 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 22% |
Other | 4 | 17% |
Student > Bachelor | 4 | 17% |
Student > Ph. D. Student | 3 | 13% |
Researcher | 2 | 9% |
Other | 2 | 9% |
Unknown | 3 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 7 | 30% |
Medicine and Dentistry | 5 | 22% |
Agricultural and Biological Sciences | 3 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 9% |
Chemical Engineering | 1 | 4% |
Other | 1 | 4% |
Unknown | 4 | 17% |